Bio-Works receives WorkBeads order worth SEK 2.5 million

Bio-Works Technologies AB has received an order for WorkBeads 40S valued at SEK 2.5 million from a returning customer in Sweden. 

The customer is a global contract development and manufacturing organization (CDMO) focused on peptide- and oligonucleotide-based therapies.
“The order from a returning global CDMO confirms our strong position in the purification of peptide- and oligonucleotide-based pharmaceuticals. It is a clear sign that Bio-Works delivers solutions that meet the highest standards of quality and performance,” says Lone Carlbom, CEO of Bio-Works.
 

This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 15-05-2025 15:02 CET.